Palm oil scandal, pharma tariffs, market jitters - what’s next for global investors?
Hosted by Michelle Martin with Ryan Huang, we unpack Wilmar International’s corruption fallout, Donald Trump’s 100% pharma tariffs, and Chugai Pharmaceutical and Novo Nordisk’s market reaction.
We explore the Buffett Indicator’s warning on U.S. equities, Nike’s upcoming earnings, and local market movers like Centurion Accommodation REIT, CapitaLand India Trust, and Jardine Matheson.
Plus, our daily UP or DOWN verdict on Lululemon, Microsoft, and more.
A fast-moving episode on scandals, stocks, and strategy.

Market View: Lululemon Plunges, S-REITs vs Banks, Nvidia’s $13B AI Bet & Why the Dutch Are Moving Gold
12:46

Advanced Diagnostic Tests the Super Health-Conscious are opting for
25:39

Money and Me: BTO Ceiling at $16K, More Homes Coming: Is Singapore Turning Into a Buyer’s Market?
21:32